News and Trends 20 Dec 2022
iOnctura raises €17.5M for pancreatic cancer therapy
iOnctura BV, a clinical-stage biotech developing novel cancer therapies, has been granted €17.5 million ($18.6 million) funding from the European Investment Council’s (EIC) accelerator program to develop IOA-289 for pancreatic…